UnitedHealth Group Beheer

Beheer criteriumcontroles 3/4

De CEO UnitedHealth Group's is Andrew Witty, benoemd in Feb2021, heeft een ambtstermijn van 3.67 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 23.53M, bestaande uit 6.4% salaris en 93.6% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.011% van de aandelen van het bedrijf, ter waarde MX$ 1.12B. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 3.1 jaar en 6.2 jaar.

Belangrijke informatie

Andrew Witty

Algemeen directeur

US$23.5m

Totale compensatie

Percentage CEO-salaris	6.4%
Dienstverband CEO	3.7yrs
Eigendom CEO	0.01%
Management gemiddelde ambtstermijn	3.1yrs
Gemiddelde ambtstermijn bestuur	6.2yrs

Recente managementupdates

Recent updates

Analyse CEO-vergoeding

Hoe is Andrew Witty's beloning veranderd ten opzichte van UnitedHealth Group's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Sep 30 2024	n/a	n/a	US$14b
Jun 30 2024	n/a	n/a	US$14b
Mar 31 2024	n/a	n/a	US$15b
Dec 31 2023	US$24m	US$2m	US$22b
Sep 30 2023	n/a	n/a	US$22b
Jun 30 2023	n/a	n/a	US$21b
Mar 31 2023	n/a	n/a	US$21b
Dec 31 2022	US$21m	US$2m	US$20b
Sep 30 2022	n/a	n/a	US$19b
Jun 30 2022	n/a	n/a	US$18b
Mar 31 2022	n/a	n/a	US$17b
Dec 31 2021	US$18m	US$1m	US$17b
Sep 30 2021	n/a	n/a	US$15b
Jun 30 2021	n/a	n/a	US$15b
Mar 31 2021	n/a	n/a	US$17b
Dec 31 2020	US$13m	US$419k	US$15b
Sep 30 2020	n/a	n/a	US$17b
Jun 30 2020	n/a	n/a	US$17b
Mar 31 2020	n/a	n/a	US$14b
Dec 31 2019	US$17m	US$1m	US$14b
Sep 30 2019	n/a	n/a	US$13b
Jun 30 2019	n/a	n/a	US$13b
Mar 31 2019	n/a	n/a	US$13b
Dec 31 2018	US$22m	US$613k	US$12b
Sep 30 2018	n/a	n/a	US$13b
Jun 30 2018	n/a	n/a	US$12b
Mar 31 2018	n/a	n/a	US$11b
Dec 31 2017	US$62k	n/a	US$11b

Compensatie versus markt: De totale vergoeding ($USD 23.53M ) Andrew } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de MX markt ($USD 5.68M ).

Compensatie versus inkomsten: De vergoeding van Andrew is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.

CEO

Andrew Witty (59 yo)

3.7yrs

Tenure

US$23,534,936

Compensatie

Sir Andrew Philip Witty has been the Chief Executive Officer and Non-Independent Director of UnitedHealth Group Incorporated since February 3, 2021 and served as its Group President since November 2019 unt...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Andrew Witty	CEO & Non-Independent Director	3.7yrs	US$23.53m	0.011% MX$ 1.1b
John Rex	President & CFO	8.3yrs	US$16.07m	0.019% MX$ 2.0b
Rupert Bondy	Senior Counsel & Executive VP of Governance	less than a year	US$6.42m	0.00042% MX$ 43.7m
Brian Thompson	Chief Executive Officer of UnitedHealthcare	no data	US$10.22m	0.0035% MX$ 368.6m
Thomas Roos	Senior VP & Chief Accounting Officer	9.2yrs	geen gegevens	0.0032% MX$ 328.0m
Sandeep Dadlani	Executive VP and Chief Digital & Technology Officer	2.1yrs	geen gegevens	geen gegevens
Zachary Sopcak	Senior Vice President of Capital Markets Communications & Investor Relations	2.6yrs	geen gegevens	geen gegevens
Chris Zaetta	Executive VP	less than a year	geen gegevens	0.00087% MX$ 90.6m
Jennifer Smoter	Senior VP & Chief Communications Officer	3.6yrs	geen gegevens	geen gegevens
James Barry	Director of Sales for Western Pennsylvania	no data	geen gegevens	geen gegevens
Terry Clark	Executive VP & Chief Marketing Officer	10.8yrs	geen gegevens	geen gegevens
Erin L. McSweeney	Executive VP & Chief People Officer	2.6yrs	geen gegevens	0.00085% MX$ 88.5m

3.1yrs

Gemiddelde duur

59yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van UNH * wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.1 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Andrew Witty	CEO & Non-Independent Director	3.7yrs	US$23.53m	0.011% MX$ 1.1b
Stephen Hemsley	Non-Independent Non-Executive Chairman	24.7yrs	US$595.35k	0.12% MX$ 12.0b
Michele Hooper	Lead Independent Director	17yrs	US$441.52k	0.00036% MX$ 37.5m
Paul Garcia	Independent Director	2.9yrs	US$366.80k	0.00034% MX$ 35.4m
Timothy Flynn	Independent Director	7.8yrs	US$400.16k	0.00038% MX$ 39.6m
Frederick McNabb	Independent Director	6.7yrs	US$392.88k	0.00070% MX$ 72.9m
John Noseworthy	Independent Director	5.7yrs	US$391.05k	geen gegevens
Valerie C. Rice	Independent Director	7.2yrs	US$391.05k	0.000040% MX$ 4.2m
Kristen Gil	Independent Director	1.8yrs	US$351.80k	0.000060% MX$ 6.2m
Charles Baker	Independent Director	less than a year	US$59.33k	geen gegevens

6.2yrs

Gemiddelde duur

67.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van UNH * wordt beschouwd als ervaren (gemiddelde ambtstermijn 6.2 jaar).

UnitedHealth Group Beheer

Beheer criteriumcontroles 3/4

Belangrijke informatie

Recente managementupdates

Senior VP & Chief Accounting Officer recently sold Mex$29m worth of stock

UnitedHealth Group Incorporated Announces Management Changes, Effective June 4, 2024

UnitedHealth Group Incorporated, Annual General Meeting, Jun 03, 2024

Executive VP & Chief People Officer recently sold Mex$10m worth of stock

Senior VP & Chief Accounting Officer recently sold Mex$7.7m worth of stock

Executive VP & CEO of UnitedHealthcare recently sold Mex$209m worth of stock

Recent updates

Third quarter 2024 earnings released: EPS: US$6.51 (vs US$6.31 in 3Q 2023)

UnitedHealth Group Incorporated Provides Earnings Guidance for the Full Year 2024

New minor risk - Share price stability

UnitedHealth Group Incorporated to Report Q3, 2024 Results on Oct 15, 2024

Upcoming dividend of US$2.10 per share

Second quarter dividend of US$2.10 announced

UnitedHealth Group Authorizes Payment of Quarterly Dividend, Payable on September 24, 2024

Senior VP & Chief Accounting Officer recently sold Mex$29m worth of stock

Second quarter 2024 earnings released: EPS: US$4.54 (vs US$5.89 in 2Q 2023)

UnitedHealth Group Incorporated to Report Q2, 2024 Results on Jul 16, 2024

First quarter dividend of US$2.10 announced

UnitedHealth Group Announces Cash Dividend, Payable on June 25, 2024

New minor risk - Share price stability

UnitedHealth Group Incorporated Announces Management Changes, Effective June 4, 2024

First quarter 2024 earnings released: US$1.53 loss per share (vs US$6.01 profit in 1Q 2023)

UnitedHealth Group Incorporated, Annual General Meeting, Jun 03, 2024

New major risk - Financial position

First quarter 2024 earnings released: US$1.53 loss per share (vs US$6.01 profit in 1Q 2023)

UnitedHealth Group Incorporated Provides Earnings Guidance for the Full Year 2024

UnitedHealth Group Incorporated to Report Q1, 2024 Results on Apr 16, 2024

Court Substantially Denies United Healthcare’s Motion for Summary Judgment in ERISA Class Action: Case Moves to Trial

Executive VP & Chief People Officer recently sold Mex$10m worth of stock

Fourth quarter dividend of US$1.88 announced

Full year 2023 earnings released: EPS: US$24.12 (vs US$21.47 in FY 2022)

Senior VP & Chief Accounting Officer recently sold Mex$7.7m worth of stock

UnitedHealth Group Announces Quarterly Dividend, Payable on March 19, 2024

Executive VP & CEO of UnitedHealthcare recently sold Mex$209m worth of stock

Unitedhealth Group Incorporated Announces Retirement of Dirk McMahon as President and Chief Operating Officer, Effective April 1, 2024

Full year 2023 earnings released: EPS: US$23.86 (vs US$21.47 in FY 2022)

UnitedHealth Group Incorporated to Report Q4, 2023 Results on Jan 12, 2024

Unitedhealth Group Incorporated Provides Earnings Guidance for the Year 2023 and 2024

Upcoming dividend of US$1.88 per share at 1.4% yield

UnitedHealth Group Incorporated Announces Cash Dividend, Payable on December 12, 2023

UnitedHealth Group Incorporated Appoints Charlie Baker to Board of Directors

Unitedhealth Group Incorporated Announces Earnings Guidance for the Full Year 2023

Third quarter 2023 earnings released: EPS: US$6.24 (vs US$5.63 in 3Q 2022)

Now 20% undervalued

UnitedHealth Group Incorporated to Report Q3, 2023 Results on Oct 13, 2023

Upcoming dividend of US$1.88 per share at 1.6% yield

Unitedhealth Group Board Authorizes Payment of Quarterly Dividend, Payable on September 19, 2023

CEO & Non-Independent Director recently sold Mex$34m worth of stock

UnitedHealth Group Incorporated Provides Earnings Guidance for the Full Year 2023

Second quarter 2023 earnings released: EPS: US$5.82 (vs US$5.41 in 2Q 2022)

Now 20% undervalued after recent price drop

UnitedHealth Group Incorporated to Report Q2, 2023 Results on Jul 14, 2023

Unitedhealth Group Incorporated Announces Quarterly Cash Dividend, Payable on June 27, 2023

Now 20% undervalued after recent price drop

Mercy Investment Files an Exempt Solicitation and Urge Vote For its Proposal

Executive VP & Chief People Office recently sold Mex$24m worth of stock

First quarter 2023 earnings released: EPS: US$5.95 (vs US$5.34 in 1Q 2022)

Now 21% undervalued after recent price drop

Full year 2022 earnings released: EPS: US$21.47 (vs US$18.33 in FY 2021)

Now 20% undervalued after recent price drop

Full year 2022 earnings released: EPS: US$21.18 (vs US$18.33 in FY 2021)

UnitedHealth Group Incorporated to Report Q4, 2022 Results on Jan 13, 2023

Kristen Gil Joins Unitedhealth Group Incorporated Board of Directors

Executive VP & Chief People Office recently sold Mex$4.8m worth of stock

Upcoming dividend of US$1.65 per share

UnitedHealth Group Incorporated Authorizes Payment of Quarterly Dividend, Payable on December 13, 2022

Third quarter 2022 earnings released: EPS: US$5.55 (vs US$4.33 in 3Q 2021)

Unitedhealth Group Incorporated Increases Earnings Guidance for the Full Year 2022

Now 23% undervalued after recent price drop

Now 20% undervalued

Judge Denies U.S. Bid to Stop UnitedHealth Plan to Buy Change

UnitedHealth Group Incorporated to Report Q3, 2022 Results on Oct 14, 2022

Upcoming dividend of US$1.65 per share

Senior VP & Chief Accounting Officer recently sold Mex$5.0m worth of stock

Amazon Reportedly Among Bidders for Signify Health

President & COO recently sold Mex$160m worth of stock